Vitamin-responsive disorders: Cobalamin, folate, biotin, vitamins B1 and E

Handbook of Clinical Neurology

Volumn 113, Issue , 2013, Pages 1799-1810

  Baumgartner, Matthias R ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876831304     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59565-2.00049-6     Document Type: Chapter

References (57)

1. Allen L.H. Causes of vitamin B12 and folate deficiency. Food Nutr Bull 2008, 29:20-34.
2. Ament A.E., Li Z., Sturm A.C., et al. Juvenile cobalamin deficiency in individuals of African ancestry is caused by a founder mutation in the intrinsic factor gene GIF. Br J Haematol 2008, 144:622-624.
3. Banerjee R., Gherasim C., Padovani D. The tinker, tailor, soldier in intracellular B12 trafficking. Curr Opin Chem Biol 2009, 13:484-491.
4. Banka S., Blom H.J., Walter J., et al. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet 2011, 88:216-225.
5. Baumgartner M.R., Suormala T. Biotin-responsive disorders. Inborn Metabolic Diseases 2006, 331-339. Springer, Berlin Heidelberg. 4th edn. J. Fernandes, J.-M. Saudubray, G. van dern Berge (Eds.).
6. Bergmann A.K., Sahai I., Falcone J.F., et al. Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. J Pediatr 2009, 155:888-892.
7. Blom H.J., Shaw G.M., Den Heijer M., et al. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 2006, 7:724-731.
8. Cario H., Smith D.E.C., Blom H., et al. Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am J Hum Genet 2011, 88:226-231.
9. Cavalier L., Ouahchi K., Kayden H.J., et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 1998, 62:301-310.
10. Chalouhi C., Faesch S., Anthoine-Milhomme M.C., et al. Neurological consequences of vitamin B12 deficiency and its treatment. Pediatr Emerg Care 2008, 24:538-541.
11. Coelho D., Suormala T., Stucki M., et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med 2008, 358:1454-1464.
12. 12 metabolism caused by mutations in ABCD4. Nat Genet 2012, 44:1152-1155.
13. Debs R., Depienne C., Rastetter A., et al. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. Arch Neurol 2010, 67:126-130.
14. 12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev 2008, 66:250-255.
15. Fattal-Valevski A., Kesler A., Sela B.A., et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics 2005, 115:233-238.
16. Fowler B., Leonard J.V., Baumgartner M.R. Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis 2008, 31:350-360.
17. Gallagher R.C., Van Hove J.L., Scharer G., et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 2009, 65:550-556.
18. Garcia-Cazorla A., Quadros E.V., Nascimento A., et al. Mitochondrial diseases associated with cerebral folate deficiency. Neurology 2008, 70:1360-1362.
19. Gordon N. Cerebral folate deficiency. Dev Med Child Neurol 2009, 51:180-182.
20. Gräsbeck R., Gordin R., Kantero I., et al. Selective vitamin B12 malabsorption and proteinuria in young people. A syndrome. Acta Med Scand 1960, 167:289-296.
21. Hall C.A. The neurological aspects of transcobalamin II deficiency. Br J Haematol 1992, 80:117-120.
22. Hörster F., Baumgartner M.R., Viardot C., et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 2007, 62:225-230.
23. Hvas A.M., Nexo E. Diagnosis and treatment of vitamin B12 deficiency. An update. Haematologica 2006, 91:1506-1512.
24. Imerslund O. Idiopathic chronic megaloblastic anemia in children. Acta Paediatr Suppl 1960, 49:111-115.
25. Katz M., Lee S.K., Cooper B.A. Vitamin B12 malabsorption due to a biologically inert intrinsic factor. N Engl J Med 1972, 287:425-429.
26. Koenig M. Rare forms of autosomal recessive neurodegenerative ataxia. Semin Pediatr Neurol 2003, 10:183-192.
27. Kono S., Miyajima H., Yoshida K., et al. Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. N Engl J Med 2009, 360:1792-1794.
28. Lerner-Ellis J.P., Anastasio N., Liu J., et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat 2009, 30:1072-1081.
29. Luder A.S., Tanner S.M., De La Chapelle A., et al. Amnionless (AMN) mutations in Imerslund-Gräsbeck syndrome may be associated with disturbed vitamin B12 transport into the CNS. J Inherit Metab Dis online 2008, 10.1007/s10545-007-0760-2.
30. Mardach R., Zempleni J., Wolf B., et al. Biotin dependency due to a defect in biotin transport. J Clin Invest 2002, 109:1617-1623.
31. Mariotti C., Gellera C., Rimoldi M., et al. Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci 2004, 25:130-137.
32. Miousse I.R., Watkins D., Coelho D., et al. Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism. J Pediatr 2009, 154:551-556.
33. Ozand P.T., Gascon G.G., Al Essa M., et al. Biotin-responsive basal ganglia disease: a novel entity. Brain 1998, 121:1267-1279.
34. Quadros E.V. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol 2009, 148:195-204.
35. 12. Hum Mutat 2010, 31:924-929.
36. Qui A., Jansen M., Sakaris A., et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006, 127:917-928.
37. Rader D.J., Brewer H.B. Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease. JAMA 1993, 270:865-869.
38. Ramaekers V.T., Rothenberg S.P., Sequeira J.M., et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005, 352:1985-1991.
39. Rasmussen S.A., Fernhoff P.M., Scanlon K.S. Vitamin B12 deficiency in children and adolescents. J Pediatr 2001, 138:10-17.
40. Ratschmann R., Minkov M., Kis A., et al. Transcobalamin II deficiency at birth. Mol Genet Metab 2009, 98:285-288.
41. Rosenblatt D.S., Fowler B. Disorders of cobalamin and folate transport and metabolism. Inborn Metabolic Diseases 2006, 341-356. Springer, Berlin Heidelberg. 4th edn. J. Fernandes, J.-M. Saudubray, G. van dern Berge (Eds.).
42. Rutsch F., Gailus S., Miousse I.R., et al. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. Nat Genet 2009, 41:234-239.
43. Sechi G.P., Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007, 6:442-455.
44. Steinfeld R., Grapp M., Kraetzner R., et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 2009, 85:254-263.
45. Stucki M., Coelho D., Suormala T., et al. Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism. Hum Mol Genet 2012, 21:1410-1418.
46. Tanner S.M., Li Z., Perko J.D., et al. Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene. PNAS 2005, 102:4130-4133.
47. Vilaseca M.A., Vilarinho L., Zavadakova P., et al. CblE type of homocystinuria: mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene. J Inherit Metab Dis 2003, 26:361-369.
48. Watkins D., Rosenblatt D.S. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet Part C Semin Med Genet 2011, 157:33-44.
49. Watkins D., Whitehead V.M., Rosenblatt D.S. Megaloblastic anemia. Nathan and Oski's Hematology of Infancy and Childhood 2009, 467-520. Saunders Elsevier, Philadelphia. 7th edn. S.H. Orkin, D. Ginsburg, D.A. Nathan (Eds.).
50. Watkins D., Schwartzentruber J.A., Ganesh J., et al. Novel inborn error of folate metabolism: identification by exome capture and sequencing of mutations in the MTHFD1 gene in a single proband. J Med Genet 2011, 48:590-592.
51. Whitehead V.M. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol 2006, 134:125-136.
52. Williams Z.R., Hurley P.E., Altiparmak U.E., et al. Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol 2009, 147:929-933.
53. Wolf B. Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab 2010, 100:6-13.
54. Yamada K., Miura K., Hara K., et al. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet 2010, 11:171.
55. Zempleni J., Hassan Y.I., Wijeratne S.S. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab 2008, 3:715-724.
56. Zeng W.Q., Al-Yamani E., Acierno J.S., et al. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am J Hum Genet 2005, 77:16-26.
57. Zhao R., Min S.H., Qiu A., et al. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood 2007, 110:1147-1152.